Antihistamine Market

Table of Content

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Product Innovation / Development Trends
4. Value Added Insights
    4.1. Product Adoption / Usage Analysis
    4.2. Product USPs / Features
    4.3. PESTLE Analysis
    4.4. Porter Analysis
    4.5. Regulatory Scenario
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global GDP Growth Outlook
        5.1.2. Global Healthcare Expenditure Outlook
        5.1.3. Global Allergy Treatment Market Outlook
    5.2. Forecast Factors - Relevance & Impact
        5.2.1. Historic Growth of the Top Companies
        5.2.2. Rising Prevalence of Allergies and Allergic Reactions
        5.2.3. Mergers and Acquisitions
        5.2.4. Strategic Collaborations
        5.2.5. Adoption Rate
        5.2.6. Product and Stock Availability
    5.3. Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ Billion) Analysis 2017 to 2022 and Forecast, 2023 to 2033
    6.1. Historical Market Value (US$ Billion) Analysis, 2017 to 2022
    6.2. Current and Future Market Value (US$ Billion) Projections, 2023 to 2033
        6.2.1. Y-o-Y Growth Trend Analysis
        6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product 
    7.1. Introduction / Key Findings
    7.2. Historical Market Size (US$ Billion) Analysis By Product, 2017 to 2022
    7.3. Current and Future Market Size (US$ Billion) and Analysis and Forecast By Product, 2023 to 2033
        7.3.1. H-1 Blockers
        7.3.2. H-2 Blockers
    7.4. Market Attractiveness Analysis By Product
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Type 
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ Billion) Analysis By Type, 2017 to 2022
    8.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Type, 2023 to 2033
        8.3.1. Prescription-based
        8.3.2. Over-the-counter
    8.4. Market Attractiveness Analysis By Type
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Forms
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ Billion) Analysis By Dosage Forms, 2017 to 2022
    9.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Dosage Forms, 2023 to 2033
        9.3.1. Tablets
        9.3.2. Capsules
        9.3.3. Liquids
        9.3.4. Other
    9.4. Market Attractiveness Analysis By Dosage Forms
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ Billion) Analysis By Route of Administration, 2017 to 2022
    10.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Route of Administration, 2023 to 2033
        10.3.1. Oral
        10.3.2. Parenteral
        10.3.3. Topical
    10.4. Market Attractiveness Analysis By Route of Administration
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication 
    11.1. Introduction / Key Findings
    11.2. Historical Market Size (US$ Billion) Analysis By Indication, 2017 to 2022
    11.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Indication, 2023 to 2033
        11.3.1. Allergies
        11.3.2. Urticaria
        11.3.3. Dermatitis
        11.3.4. Others
    11.4. Market Attractiveness Analysis By Indication
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
    12.1. Introduction / Key Findings
    12.2. Historical Market Size (US$ Billion) Analysis By Distribution Channel, 2017 to 2022
    12.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Distribution Channel, 2023 to 2033
        12.3.1. Hospital Pharmacies
        12.3.2. Retail Pharmacies
        12.3.3. Drug Stores
        12.3.4. Online Pharmacies
    12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
    13.1. Introduction
    13.2. Historical Market Size (US$ Billion) Analysis By Region, 2017 to 2022
    13.3. Current Market Size (US$ Billion) Analysis and Forecast By Region, 2023 to 2033
        13.3.1. North America
        13.3.2. Latin America
        13.3.3. Europe
        13.3.4. South Asia
        13.3.5. East Asia
        13.3.6. Oceania
        13.3.7. Middle East and Africa (MEA)
    13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    14.1. Introduction
    14.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    14.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        14.3.1. By Country
            14.3.1.1. USA
            14.3.1.2. Canada
        14.3.2. By Product
        14.3.3. By Type
        14.3.4. By Dosage Forms
        14.3.5. By Route of Administration
        14.3.6. By Indication
        14.3.7. By Distribution Channel
    14.4. Market Attractiveness Analysis
        14.4.1. By Country
        14.4.2. By Product
        14.4.3. By Type
        14.4.4. By Dosage Forms
        14.4.5. By Route of Administration
        14.4.6. By Indication
        14.4.7. By Distribution Channel
    14.5. Country Level Analysis & Forecast
        14.5.1. USA Market Analysis
            14.5.1.1. Introduction
            14.5.1.2. Market Analysis and Forecast by Market Taxonomy
                14.5.1.2.1. By Product
                14.5.1.2.2. By Type
                14.5.1.2.3. By Dosage Forms
                14.5.1.2.4. By Route of Administration
                14.5.1.2.5. By Indication
                14.5.1.2.6. By Distribution Channel
        14.5.2. Canada Market Analysis
            14.5.2.1. Introduction
            14.5.2.2. Market Analysis and Forecast by Market Taxonomy
                14.5.2.2.1. By Product
                14.5.2.2.2. By Type
                14.5.2.2.3. By Dosage Forms
                14.5.2.2.4. By Route of Administration
                14.5.2.2.5. By Indication
                14.5.2.2.6. By Distribution Channel
    14.6. Market Trends
    14.7. Key Market Participants - Intensity Mapping
    14.8. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    15.1. Introduction
    15.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    15.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        15.3.1. By Country
            15.3.1.1. Brazil
            15.3.1.2. Mexico
            15.3.1.3. Argentina
            15.3.1.4. Rest of Latin America
        15.3.2. By Product
        15.3.3. By Type
        15.3.4. By Dosage Forms
        15.3.5. By Route of Administration
        15.3.6. By Indication
        15.3.7. By Distribution Channel
    15.4. Market Attractiveness Analysis
        15.4.1. By Country
        15.4.2. By Product
        15.4.3. By Type
        15.4.4. By Dosage Forms
        15.4.5. By Route of Administration
        15.4.6. By Indication
        15.4.7. By Distribution Channel
    15.5. Country Level Analysis & Forecast
        15.5.1. Brazil Market Analysis
            15.5.1.1. Introduction
            15.5.1.2. Market Analysis and Forecast by Market Taxonomy
                15.5.1.2.1. By Product
                15.5.1.2.2. By Type
                15.5.1.2.3. By Dosage Forms
                15.5.1.2.4. By Route of Administration
                15.5.1.2.5. By Indication
                15.5.1.2.6. By Distribution Channel
        15.5.2. Mexico Market Analysis
            15.5.2.1. Introduction
            15.5.2.2. Market Analysis and Forecast by Market Taxonomy
                15.5.2.2.1. By Product
                15.5.2.2.2. By Type
                15.5.2.2.3. By Dosage Forms
                15.5.2.2.4. By Route of Administration
                15.5.2.2.5. By Indication
                15.5.2.2.6. By Distribution Channel
        15.5.3. Argentina Market Analysis
            15.5.3.1. Introduction
            15.5.3.2. Market Analysis and Forecast by Market Taxonomy
                15.5.3.2.1. By Product
                15.5.3.2.2. By Type
                15.5.3.2.3. By Dosage Forms
                15.5.3.2.4. By Route of Administration
                15.5.3.2.5. By Indication
                15.5.3.2.6. By Distribution Channel
    15.6. Market Trends
    15.7. Key Market Participants - Intensity Mapping
    15.8. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    16.1. Introduction
    16.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    16.3. Market Size (US$ Billion) Forecast, By Market Taxonomy, 2023 to 2033
        16.3.1. By Country
            16.3.1.1. Germany
            16.3.1.2. France
            16.3.1.3. Italy
            16.3.1.4. UK
            16.3.1.5. Spain
            16.3.1.6. Russia
            16.3.1.7. BENELUX
            16.3.1.8. Nordic Countries
            16.3.1.9. Rest of Europe
        16.3.2. By Product
        16.3.3. By Type
        16.3.4. By Dosage Forms
        16.3.5. By Route of Administration
        16.3.6. By Indication
        16.3.7. By Distribution Channel
    16.4. Market Attractiveness Analysis
        16.4.1. By Country
        16.4.2. By Product
        16.4.3. By Type
        16.4.4. By Dosage Forms
        16.4.5. By Route of Administration
        16.4.6. By Indication
        16.4.7. By Distribution Channel
    16.5. Country Level Analysis & Forecast
        16.5.1. Germany Market Analysis
            16.5.1.1. Introduction
            16.5.1.2. Market Analysis and Forecast by Market Taxonomy
                16.5.1.2.1. By Product
                16.5.1.2.2. By Type
                16.5.1.2.3. By Dosage Forms
                16.5.1.2.4. By Route of Administration
                16.5.1.2.5. By Indication
                16.5.1.2.6. By Distribution Channel
        16.5.2. France Market Analysis
            16.5.2.1. Introduction
            16.5.2.2. Market Analysis and Forecast by Market Taxonomy
                16.5.2.2.1. By Product
                16.5.2.2.2. By Type
                16.5.2.2.3. By Dosage Forms
                16.5.2.2.4. By Route of Administration
                16.5.2.2.5. By Indication
                16.5.2.2.6. By Distribution Channel
        16.5.3. Italy Market Analysis
            16.5.3.1. Introduction
            16.5.3.2. Market Analysis and Forecast by Market Taxonomy
                16.5.3.2.1. By Product
                16.5.3.2.2. By Type
                16.5.3.2.3. By Dosage Forms
                16.5.3.2.4. By Route of Administration
                16.5.3.2.5. By Indication
                16.5.3.2.6. By Distribution Channel
        16.5.4. UK Market Analysis
            16.5.4.1. Introduction
            16.5.4.2. Market Analysis and Forecast by Market Taxonomy
                16.5.4.2.1. By Product
                16.5.4.2.2. By Type
                16.5.4.2.3. By Dosage Forms
                16.5.4.2.4. By Route of Administration
                16.5.4.2.5. By Indication
                16.5.4.2.6. By Distribution Channel
        16.5.5. Spain Market Analysis
            16.5.5.1. Introduction
            16.5.5.2. Market Analysis and Forecast by Market Taxonomy
                16.5.5.2.1. By Product
                16.5.5.2.2. By Type
                16.5.5.2.3. By Dosage Forms
                16.5.5.2.4. By Route of Administration
                16.5.5.2.5. By Indication
                16.5.5.2.6. By Distribution Channel
        16.5.6. Russia Market Analysis
            16.5.6.1. Introduction
            16.5.6.2. Market Analysis and Forecast by Market Taxonomy
                16.5.6.2.1. By Product
                16.5.6.2.2. By Type
                16.5.6.2.3. By Dosage Forms
                16.5.6.2.4. By Route of Administration
                16.5.6.2.5. By Indication
                16.5.6.2.6. By Distribution Channel
        16.5.7. Nordic Countries Market Analysis
            16.5.7.1. Introduction
            16.5.7.2. Market Analysis and Forecast by Market Taxonomy
                16.5.7.2.1. By Product
                16.5.7.2.2. By Type
                16.5.7.2.3. By Dosage Forms
                16.5.7.2.4. By Route of Administration
                16.5.7.2.5. By Indication
                16.5.7.2.6. By Distribution Channel
        16.5.8. BENELUX Market Analysis
            16.5.8.1. Introduction
            16.5.8.2. Market Analysis and Forecast by Market Taxonomy
                16.5.8.2.1. By Product
                16.5.8.2.2. By Type
                16.5.8.2.3. By Dosage Forms
                16.5.8.2.4. By Route of Administration
                16.5.8.2.5. By Indication
                16.5.8.2.6. By Distribution Channel
    16.6. Market Trends
    16.7. Key Market Participants - Intensity Mapping
    16.8. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    17.1. Introduction
    17.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    17.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        17.3.1. By Country
            17.3.1.1. India
            17.3.1.2. Thailand
            17.3.1.3. Indonesia
            17.3.1.4. Malaysia
            17.3.1.5. Rest of South Asia
        17.3.2. By Product
        17.3.3. By Type
        17.3.4. By Dosage Forms
        17.3.5. By Route of Administration
        17.3.6. By Indication
        17.3.7. By Distribution Channel
    17.4. Market Attractiveness Analysis
        17.4.1. By Country
        17.4.2. By Product
        17.4.3. By Type
        17.4.4. By Dosage Forms
        17.4.5. By Route of Administration
        17.4.6. By Indication
        17.4.7. By Distribution Channel
    17.5. Country Level Analysis & Forecast
        17.5.1. India Market Analysis
            17.5.1.1. Introduction
            17.5.1.2. Market Analysis and Forecast by Market Taxonomy
                17.5.1.2.1. By Product
                17.5.1.2.2. By Type
                17.5.1.2.3. By Dosage Forms
                17.5.1.2.4. By Route of Administration
                17.5.1.2.5. By Indication
                17.5.1.2.6. By Distribution Channel
        17.5.2. Thailand Market Analysis
            17.5.2.1. Introduction
            17.5.2.2. Market Analysis and Forecast by Market Taxonomy
                17.5.2.2.1. By Product
                17.5.2.2.2. By Type
                17.5.2.2.3. By Dosage Forms
                17.5.2.2.4. By Route of Administration
                17.5.2.2.5. By Indication
                17.5.2.2.6. By Distribution Channel
        17.5.3. Indonesia Market Analysis
            17.5.3.1. Introduction
            17.5.3.2. Market Analysis and Forecast by Market Taxonomy
                17.5.3.2.1. By Product
                17.5.3.2.2. By Type
                17.5.3.2.3. By Dosage Forms
                17.5.3.2.4. By Route of Administration
                17.5.3.2.5. By Indication
                17.5.3.2.6. By Distribution Channel
        17.5.4. Malaysia Market Analysis
            17.5.4.1. Introduction
            17.5.4.2. Market Analysis and Forecast by Market Taxonomy
                17.5.4.2.1. By Product
                17.5.4.2.2. By Type
                17.5.4.2.3. By Dosage Forms
                17.5.4.2.4. By Route of Administration
                17.5.4.2.5. By Indication
                17.5.4.2.6. By Distribution Channel
    17.6. Market Trends
    17.7. Key Market Participants - Intensity Mapping
    17.8. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    18.1. Introduction
    18.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    18.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        18.3.1. By Country
            18.3.1.1. China
            18.3.1.2. Japan
            18.3.1.3. South Korea
        18.3.2. By Product
        18.3.3. By Type
        18.3.4. By Dosage Forms
        18.3.5. By Route of Administration
        18.3.6. By Indication
        18.3.7. By Distribution Channel
    18.4. Market Attractiveness Analysis
        18.4.1. By Country
        18.4.2. By Product
        18.4.3. By Type
        18.4.4. By Dosage Forms
        18.4.5. By Route of Administration
        18.4.6. By Indication
        18.4.7. By Distribution Channel
    18.5. Country Level Analysis & Forecast
        18.5.1. China Market Analysis
            18.5.1.1. Introduction
            18.5.1.2. Market Analysis and Forecast by Market Taxonomy
                18.5.1.2.1. By Product
                18.5.1.2.2. By Type
                18.5.1.2.3. By Dosage Forms
                18.5.1.2.4. By Route of Administration
                18.5.1.2.5. By Indication
                18.5.1.2.6. By Distribution Channel
        18.5.2. Japan Market Analysis
            18.5.2.1. Introduction
            18.5.2.2. Market Analysis and Forecast by Market Taxonomy
                18.5.2.2.1. By Product
                18.5.2.2.2. By Type
                18.5.2.2.3. By Dosage Forms
                18.5.2.2.4. By Route of Administration
                18.5.2.2.5. By Indication
                18.5.2.2.6. By Distribution Channel
        18.5.3. South Korea Market Analysis
            18.5.3.1. Introduction
            18.5.3.2. Market Analysis and Forecast by Market Taxonomy
                18.5.3.2.1. By Product
                18.5.3.2.2. By Type
                18.5.3.2.3. By Dosage Forms
                18.5.3.2.4. By Route of Administration
                18.5.3.2.5. By Indication
                18.5.3.2.6. By Distribution Channel
    18.6. Market Trends
    18.7. Key Market Participants - Intensity Mapping
    18.8. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    19.1. Introduction
    19.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    19.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        19.3.1. By Country
            19.3.1.1. Australia
            19.3.1.2. New Zealand
        19.3.2. By Product
        19.3.3. By Type
        19.3.4. By Dosage Forms
        19.3.5. By Route of Administration
        19.3.6. By Indication
        19.3.7. By Distribution Channel
    19.4. Market Attractiveness Analysis
        19.4.1. By Country
        19.4.2. By Product
        19.4.3. By Type
        19.4.4. By Dosage Forms
        19.4.5. By Route of Administration
        19.4.6. By Indication
        19.4.7. By Distribution Channel
    19.5. Country Level Analysis & Forecast
        19.5.1. Australia Market Analysis
            19.5.1.1. Introduction
            19.5.1.2. Market Analysis and Forecast by Market Taxonomy
                19.5.1.2.1. By Product
                19.5.1.2.2. By Type
                19.5.1.2.3. By Dosage Forms
                19.5.1.2.4. By Route of Administration
                19.5.1.2.5. By Indication
                19.5.1.2.6. By Distribution Channel
        19.5.2. New Zealand Market Analysis
            19.5.2.1. Introduction
            19.5.2.2. Market Analysis and Forecast by Market Taxonomy
                19.5.2.2.1. By Product
                19.5.2.2.2. By Type
                19.5.2.2.3. By Dosage Forms
                19.5.2.2.4. By Route of Administration
                19.5.2.2.5. By Indication
                19.5.2.2.6. By Distribution Channel
    19.6. Market Trends
    19.7. Key Market Participants - Intensity Mapping
    19.8. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    20.1. Introduction
    20.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022
    20.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033
        20.3.1. By Country
            20.3.1.1. GCC Countries
            20.3.1.2. Türkiye
            20.3.1.3. Northern Africa
            20.3.1.4. South Africa
            20.3.1.5. Rest of Middle East and Africa
        20.3.2. By Product
        20.3.3. By Type
        20.3.4. By Dosage Forms
        20.3.5. By Route of Administration
        20.3.6. By Indication
        20.3.7. By Distribution Channel
    20.4. Market Attractiveness Analysis
        20.4.1. By Country
        20.4.2. By Product
        20.4.3. By Type
        20.4.4. By Dosage Forms
        20.4.5. By Route of Administration
        20.4.6. By Indication
        20.4.7. By Distribution Channel
    20.5. Country Level Analysis & Forecast
        20.5.1. GCC Countries Market Analysis
            20.5.1.1. Introduction
            20.5.1.2. Market Analysis and Forecast by Market Taxonomy
                20.5.1.2.1. By Product Type
                20.5.1.2.2. By Route of Administration
                20.5.1.2.3. By Indication
                20.5.1.2.4. By Distribution Channel
        20.5.2. Türkiye Market Analysis
            20.5.2.1. Introduction
            20.5.2.2. Market Analysis and Forecast by Market Taxonomy
                20.5.2.2.1. By Product
                20.5.2.2.2. By Type
                20.5.2.2.3. By Dosage Forms
                20.5.2.2.4. By Route of Administration
                20.5.2.2.5. By Indication
                20.5.2.2.6. By Distribution Channel
        20.5.3. Northern Africa Market Analysis
            20.5.3.1. Introduction
            20.5.3.2. Market Analysis and Forecast by Market Taxonomy
                20.5.3.2.1. By Product
                20.5.3.2.2. By Type
                20.5.3.2.3. By Dosage Forms
                20.5.3.2.4. By Route of Administration
                20.5.3.2.5. By Indication
                20.5.3.2.6. By Distribution Channel
        20.5.4. South Africa Market Analysis
            20.5.4.1. Introduction
            20.5.4.2. Market Analysis and Forecast by Market Taxonomy
                20.5.4.2.1. By Product
                20.5.4.2.2. By Type
                20.5.4.2.3. By Dosage Forms
                20.5.4.2.4. By Route of Administration
                20.5.4.2.5. By Indication
                20.5.4.2.6. By Distribution Channel
    20.6. Market Trends
    20.7. Key Market Participants - Intensity Mapping
    20.8. Drivers and Restraints - Impact Analysis
21. Market Structure Analysis
    21.1. Market Analysis by Tier of Companies
    21.2. Market Share Analysis of Top Players
    21.3. Market Presence Analysis
22. Competition Analysis
    22.1. Competition Dashboard
    22.2. Competition Benchmarking
    22.3. Competition Deep Dive
        22.3.1. GlaxoSmithKline PLC.
            22.3.1.1. Overview
            22.3.1.2. Product Portfolio
            22.3.1.3. Profitability by Market Segments (Product/Region)
            22.3.1.4. Sales Footprint
            22.3.1.5. Strategy Overview
        22.3.2. Sanofi Consumer Healthcare
        22.3.3. Himalaya Wellness Company
        22.3.4. Sun Pharmaceutical Industries, Inc.
        22.3.5. Bayer AG
        22.3.6. Novartis AG
        22.3.7. Cadila Pharmaceuticals
        22.3.8. Bausch Health Companies Inc.
        22.3.9. Alcon Vision LLC.
        22.3.10. Merck & Co.
        22.3.11. Dr. Reddy’s Laboratories, Ltd.
        22.3.12. Viatris Inc.
        22.3.13. Somerset Pharma, LLC
        22.3.14. F. Hoffmann- La Roche Ltd.
        22.3.15. Akorn Operating Company LLC
        22.3.16. Teva Pharmaceutical Industries Ltd.
        22.3.17. Speer laboratories
        22.3.18. Glenmark Pharmaceuticals Limited
        22.3.19. TerSera Therapeutics LLC
        22.3.20. Pfizer Inc.
        22.3.21. Johnson & Johnson Consumer Inc.
        22.3.22. Pharmaceutical Specialties Inc.
        22.3.23. Proctor & Gamble
23. Assumptions and Acronyms Used
24. Research Methodology